Revelation Biosciences Inc - Warrants(10/01/2027)
REVBW
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.28M
Close$
$1.60
11602.9% upside
Current Fair Value
11602.9% upsideUndervalued by 11602.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.28 Million |
|---|---|
| Enterprise Value | $-9,074,651.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-23.95 |
| Beta | 2.6 |
| Outstanding Shares | 3,207,720 |
Return
| Return on Equity | -114471.39% |
|---|---|
| Return on Assets | -98832.47% |
| Return on Invested Capital | -109049.52% |
Valuation & Multiples
| P/E Ratio | -0.36 |
|---|---|
| PEG | -0.11 |
| Price to Sales | - |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.08 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 11, 2026
EPS Estimate
$-2.13
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 7, 2026
EPS Estimate
$-0.83
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 10.04%▼ 111.98% |
|---|---|
| Total Invested | $5,017▼ 50.93% |
| Investors Holding | 8▼ 3.00% |
ESG Score
No data
About Revelation Biosciences Inc
2 employees